1. Home
  2. IMUX vs TSE Comparison

IMUX vs TSE Comparison

Compare IMUX & TSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMUX
  • TSE
  • Stock Information
  • Founded
  • IMUX 2016
  • TSE 2010
  • Country
  • IMUX United States
  • TSE United States
  • Employees
  • IMUX N/A
  • TSE N/A
  • Industry
  • IMUX Biotechnology: Pharmaceutical Preparations
  • TSE Major Chemicals
  • Sector
  • IMUX Health Care
  • TSE Industrials
  • Exchange
  • IMUX Nasdaq
  • TSE Nasdaq
  • Market Cap
  • IMUX 90.4M
  • TSE 83.1M
  • IPO Year
  • IMUX N/A
  • TSE 2014
  • Fundamental
  • Price
  • IMUX $0.79
  • TSE $2.45
  • Analyst Decision
  • IMUX Strong Buy
  • TSE
  • Analyst Count
  • IMUX 5
  • TSE 0
  • Target Price
  • IMUX $7.50
  • TSE N/A
  • AVG Volume (30 Days)
  • IMUX 1.3M
  • TSE 235.5K
  • Earning Date
  • IMUX 11-06-2025
  • TSE 11-05-2025
  • Dividend Yield
  • IMUX N/A
  • TSE 1.64%
  • EPS Growth
  • IMUX N/A
  • TSE N/A
  • EPS
  • IMUX N/A
  • TSE N/A
  • Revenue
  • IMUX N/A
  • TSE $3,258,300,000.00
  • Revenue This Year
  • IMUX N/A
  • TSE N/A
  • Revenue Next Year
  • IMUX N/A
  • TSE $4.84
  • P/E Ratio
  • IMUX N/A
  • TSE N/A
  • Revenue Growth
  • IMUX N/A
  • TSE N/A
  • 52 Week Low
  • IMUX $0.56
  • TSE $1.90
  • 52 Week High
  • IMUX $2.11
  • TSE $7.05
  • Technical
  • Relative Strength Index (RSI)
  • IMUX 42.07
  • TSE 49.39
  • Support Level
  • IMUX $0.74
  • TSE $2.26
  • Resistance Level
  • IMUX $0.90
  • TSE $2.55
  • Average True Range (ATR)
  • IMUX 0.06
  • TSE 0.14
  • MACD
  • IMUX -0.00
  • TSE 0.02
  • Stochastic Oscillator
  • IMUX 25.02
  • TSE 48.81

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

About TSE Trinseo PLC

Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.

Share on Social Networks: